Library

Protocol

Sermorelin (5mg Vial)

Complete dosage protocol and reconstitution guide for Sermorelin (5mg Vial).

Updated November 26, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismSermorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that stimulates endogenous pituitary GH secretion [1] . Originally approved for pediatric growth hormone deficiency, it is studied for adult off‑label use to support physiologic GH output and IGF‑1 levels [2] .
Dosing200–500 µg once daily at bedtime (gradual titration).
ReconstitutionAdd 3.0 mL diluent to a 5 mg vial.
StorageLyophilized: refrigerate at 2–8 °C (36–46 °F) ; after reconstitution, refrigerate at 2–8 °C (36–46 °F) and use within 10–14 days [4] .

Calculator preset

Run the vial math before tracking.

At ~1.67 mg/mL, 1 unit ~ 16.7 mcg ; 200 mcg ~ 12 units and 500 mcg ~ 30 units on a U-100 syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

Sermorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that stimulates endogenous pituitary GH secretion [1] . Originally approved for pediatric growth hormone deficiency, it is studied for adult off‑label use to support physiologic GH output and IGF‑1 levels [2] . This educational protocol presents a once‑daily subcutaneous approach administered at bedtime to align with natural nocturnal GH release [3] .

ReconstituteAdd 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration.
Reference dose200–500 µg once daily at bedtime (gradual titration).
Easy measuringAt ~1.67 mg/mL, 1 unit ~ 16.7 mcg ; 200 mcg ~ 12 units and 500 mcg ~ 30 units on a U-100 syringe.
StorageLyophilized: refrigerate at 2–8 °C (36–46 °F) ; after reconstitution, refrigerate at 2–8 °C (36–46 °F) and use within 10–14 days [4] .
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–2200 µg12 units (0.12 mL)
Weeks 3–4300 µg18 units (0.18 mL)
Weeks 5–6400 µg24 units (0.24 mL)
Weeks 7–8500 µg30 units (0.30 mL)

200–500 µg once daily at bedtime (gradual titration).

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; gently swirl to dissolve (do not shake vigorously) [2] .
  3. Label with reconstitution date and refrigerate at 2–8 °C (36–46 °F) , protected from light [2] [4] .
  4. Wipe vial stopper with alcohol before each use; use a new sterile needle and syringe for each injection [2] .

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide Vials 8 weeks (total ~19.6 mg consumed): 4 vials (20 mg total)
  • 12 weeks (similar daily range): 6–7 vials Tip: Have 1 extra vial as backup in case of spillage or loss.
Insulin Syringes Per week: 7 syringes (1/day)
  • 8 weeks: 56 syringes (recommend 1 × 100‑count box)
  • 12 weeks: 84 syringes (1 × 100‑count box) Preferred: 0.3–0.5 mL size with 28G–31G needle, 5/16″ to 1/2″ length for subcutaneous use.
Bacteriostatic Water Use ~3.0 mL per vial for reconstitution.
  • 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
  • 12 weeks (7 vials): 21 mL → 3 × 10 mL bottles Contains benzyl alcohol preservative; do not use if allergic.
Alcohol Swabs One for the vial stopper + one for the injection site each day.
  • Per week: 14 swabs (2/day)
  • 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
  • 12 weeks: 168 swabs → recommend 2 × 100‑count boxes Sharps Container: One puncture‑proof disposal container for used needles (sufficient for 56+ syringes).

Protocol Overview

  • Goal: Stimulate endogenous pituitary GH release to support physiologic IGF‑1 levels and anabolic processes [1] [2] .
  • Schedule: Daily subcutaneous injections at bedtime for 3–6 months (pediatric trials ran 6–12 months; adult use is off‑label) [1] .
  • Dose Range: 200–500 µg daily (adult research range; pediatric: 30 µg/kg nightly) [1] [2] .
  • Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized refrigerated; reconstituted refrigerated and used within 10–14 days [4] .

Dosing Protocol

  • Suggested nightly titration approach for adult off‑label use.
  • Start: 200 µg nightly at bedtime; increase by ~100 µg every 1–2 weeks as tolerated.
  • Target: 300–500 µg nightly by Weeks 5–8 (adjust based on IGF‑1 response).
  • Frequency: Once per day (subcutaneous, preferably before sleep) [3] .
  • Cycle Length: 3–6 months typical for adult research use; pediatric trials ran 6–12 months [1] .
  • Timing: Bedtime administration leverages natural nocturnal GH pulse; rotate injection sites systematically [7] .

Storage Instructions

  • Lyophilized: refrigerate at 2–8 °C (36–46 °F) ; after reconstitution, refrigerate at 2–8 °C (36–46 °F) and use within 10–14 days [4] .
  • Storage: Lyophilized refrigerated; reconstituted refrigerated and used within 10–14 days [4] .
  • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

  • Practical considerations for consistency, safety, and optimal response.
  • Bedtime dosing is critical: Sermorelin works best when administered before sleep to align with the natural nocturnal GH pulse [3] .
  • Use new sterile insulin syringes; dispose in a designated sharps container after each use [7] .
  • Rotate injection sites systematically (abdomen, thighs, upper arms) to prevent irritation or lipohypertrophy [7] .
  • Inject slowly subcutaneously; wait a few seconds before withdrawing the needle to ensure full delivery.
  • Monitor IGF‑1 levels at baseline and periodically (every 1–2 months) to confirm response and adjust dosing if needed.
  • Check thyroid function if using long‑term, as subclinical hypothyroidism can blunt GH response [5] .

05 · How it works

How This Works

Sermorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that stimulates endogenous pituitary GH secretion [1] .

Originally approved for pediatric growth hormone deficiency, it is studied for adult off‑label use to support physiologic GH output and IGF‑1 levels [2] .

This educational protocol presents a once‑daily subcutaneous approach administered at bedtime to align with natural nocturnal GH release [3] .

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • Sermorelin observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.

Related pages

Keep researching